Total depression and subtypes in prostate cancer survivors 10 years after treatment

C. F. Sharpley, V. Bitsika, David R H Christie, R. Bradford, A. Steigler, J. W. Denham

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10 years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10 years previously completed the Zung Self-rating Depression Scale and a background questionnaire. Prevalence rates for clinically significant depression and severe depression were higher than those reported for the non-PCa men of the same age in Australia. The most common subtype of depression was Anhedonia, followed by Cognitive depression. Change in eating habits was the most powerful depression symptom predicting Anhedonia. By providing the first detailed documentation of major depression prevalence in PCa survivors, plus describing the nature of that depression, these data suggest that there is an ongoing need to provide treatments for these men and that those treatments should be focussed upon loss of previously available sources of enjoyment.

Original languageEnglish
Article numbere12630
Number of pages7
JournalEuropean Journal of Cancer Care
Volume26
Issue number6
Early online date22 Dec 2016
DOIs
Publication statusPublished - Nov 2017

Fingerprint

Survivors
Prostatic Neoplasms
Depression
Anhedonia
Therapeutics
Feeding Behavior
Documentation
Neoplasms

Cite this

Sharpley, C. F., Bitsika, V., Christie, D. R. H., Bradford, R., Steigler, A., & Denham, J. W. (2017). Total depression and subtypes in prostate cancer survivors 10 years after treatment. European Journal of Cancer Care, 26(6), [e12630]. https://doi.org/10.1111/ecc.12630
Sharpley, C. F. ; Bitsika, V. ; Christie, David R H ; Bradford, R. ; Steigler, A. ; Denham, J. W. / Total depression and subtypes in prostate cancer survivors 10 years after treatment. In: European Journal of Cancer Care. 2017 ; Vol. 26, No. 6.
@article{169dd7b23a994862bec3af63ce4d562b,
title = "Total depression and subtypes in prostate cancer survivors 10 years after treatment",
abstract = "To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10 years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10 years previously completed the Zung Self-rating Depression Scale and a background questionnaire. Prevalence rates for clinically significant depression and severe depression were higher than those reported for the non-PCa men of the same age in Australia. The most common subtype of depression was Anhedonia, followed by Cognitive depression. Change in eating habits was the most powerful depression symptom predicting Anhedonia. By providing the first detailed documentation of major depression prevalence in PCa survivors, plus describing the nature of that depression, these data suggest that there is an ongoing need to provide treatments for these men and that those treatments should be focussed upon loss of previously available sources of enjoyment.",
author = "Sharpley, {C. F.} and V. Bitsika and Christie, {David R H} and R. Bradford and A. Steigler and Denham, {J. W.}",
year = "2017",
month = "11",
doi = "10.1111/ecc.12630",
language = "English",
volume = "26",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",
number = "6",

}

Sharpley, CF, Bitsika, V, Christie, DRH, Bradford, R, Steigler, A & Denham, JW 2017, 'Total depression and subtypes in prostate cancer survivors 10 years after treatment' European Journal of Cancer Care, vol. 26, no. 6, e12630. https://doi.org/10.1111/ecc.12630

Total depression and subtypes in prostate cancer survivors 10 years after treatment. / Sharpley, C. F.; Bitsika, V.; Christie, David R H; Bradford, R.; Steigler, A.; Denham, J. W.

In: European Journal of Cancer Care, Vol. 26, No. 6, e12630, 11.2017.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Total depression and subtypes in prostate cancer survivors 10 years after treatment

AU - Sharpley, C. F.

AU - Bitsika, V.

AU - Christie, David R H

AU - Bradford, R.

AU - Steigler, A.

AU - Denham, J. W.

PY - 2017/11

Y1 - 2017/11

N2 - To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10 years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10 years previously completed the Zung Self-rating Depression Scale and a background questionnaire. Prevalence rates for clinically significant depression and severe depression were higher than those reported for the non-PCa men of the same age in Australia. The most common subtype of depression was Anhedonia, followed by Cognitive depression. Change in eating habits was the most powerful depression symptom predicting Anhedonia. By providing the first detailed documentation of major depression prevalence in PCa survivors, plus describing the nature of that depression, these data suggest that there is an ongoing need to provide treatments for these men and that those treatments should be focussed upon loss of previously available sources of enjoyment.

AB - To describe the prevalence, severity and nature of depression in a sample of prostate cancer (PCa) survivors 10 years after diagnosis and treatment, 146 Australian patients from the RADAR trial who received their diagnosis 10 years previously completed the Zung Self-rating Depression Scale and a background questionnaire. Prevalence rates for clinically significant depression and severe depression were higher than those reported for the non-PCa men of the same age in Australia. The most common subtype of depression was Anhedonia, followed by Cognitive depression. Change in eating habits was the most powerful depression symptom predicting Anhedonia. By providing the first detailed documentation of major depression prevalence in PCa survivors, plus describing the nature of that depression, these data suggest that there is an ongoing need to provide treatments for these men and that those treatments should be focussed upon loss of previously available sources of enjoyment.

UR - http://www.scopus.com/inward/record.url?scp=85007106966&partnerID=8YFLogxK

U2 - 10.1111/ecc.12630

DO - 10.1111/ecc.12630

M3 - Article

VL - 26

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

IS - 6

M1 - e12630

ER -

Sharpley CF, Bitsika V, Christie DRH, Bradford R, Steigler A, Denham JW. Total depression and subtypes in prostate cancer survivors 10 years after treatment. European Journal of Cancer Care. 2017 Nov;26(6). e12630. https://doi.org/10.1111/ecc.12630